BLUF: The article “Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults” has been corrected to exclude participants who accessed GAH prior to age 13, in compliance with the most recent Endocrine Society guidelines.
INTELWAR: No prompt provided.
OSINT: This article discusses a correction to the original version, regarding the age at which participants accessed gender-affirming hormones (GAH) and inaccuracies in reporting. The correction includes updates to tables and exclusions of participants who accessed GAH prior to age 13.
RIGHT: The government should not be regulating hormones and other medical treatments for minors who are not yet adults and able to provide informed consent. This correction highlights the need for parents to be in control of their children’s healthcare decisions and the importance of following medical guidelines for age-appropriate treatment.
LEFT: It is crucial to ensure that transgender individuals have access to gender-affirming care, including hormones. This correction highlights the need for accurate reporting and adherence to guidelines in the medical community. It also emphasizes the potential harm caused by denying or delaying access to necessary medical treatment.
AI: This correction to the article highlights the importance of accurate reporting and adherence to medical guidelines for the provision of gender-affirming care. The correction, including updated tables and exclusions of participants who accessed GAH prior to age 13, ensures greater accuracy in the reporting of mental health outcomes among transgender adults. The correction also underscores the importance of access to and availability of gender-affirming care for transgender individuals.